We've received some more positive feedback from one of our US pharma clients. Here's what our client had to say: "Hypha Discovery has been a valuable metabolite ID partner. Hypha...
We were delighted to welcome some new recruits to the Hypha family this October. Chloe Herring and John Boyle join the Chemistry team and Charlotte Woods joins the Microbiology team.
Hypha's paper in ACS Medicinal Chemistry Letters on "Biotransformation: Impact and Application of Metabolism in Drug Discovery" was published in August 2020. This article discusses the impact and application of...
Check out a new white paper describing the joint efforts of Hypha and Galchimia, who together successfully synthesised metabolites of the herbicide napropamide using a complementary approach of chemical synthesis...
Hypha were honoured to be asked to contribute a chapter on "Metabolite Generation and Metabolite Characterization by NMR" in the book just published on "Identification and Quantification of Drugs, Metabolites,...
This is an exciting opportunity for an intern to spend time on a research project to further exemplify the use of Hypha’s new enzyme reagents to synthesise conjugated drug metabolites....
Hypha are excited to announce they have relocated from Slough to Milton Park in Oxfordshire, one of the largest science clusters in the UK. Our new address is 154B Brook...
Metabolites derived from any human flavin-containing monooxygenase (FMO) subtype can now be produced as a service offering at Hypha. Recombinant enzymes of all five forms of human FMOs have been...
Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the journal Pharmacology Research & Perspectives. There are several pathways involved...
Hypha remain fully operational and are monitoring the COVID-19 situation closely. We have implemented a number of measures in response to the guidelines issued by the UK Government to ensure...
